Butorphanol (Tartrate)

Butorphanol (Tartrate) is opioid analgesic. Butorphanol (Tartrate) is used to relieve the pain. It has some narcotic activity. Butorphanol (Tartrate) is used to relieve pain of surgical procedures and labor and to enhance the effects of anesthesia. its long term use can produce dependence, In case of overdose its antidote is raloxone.


Adult Dose
Dose: 1 mg
Single Dose: 1 (1)
Frequency: 4 hourly
Route: IM
Instructions:
Neonatal
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Paedriatic
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Characteristics
Butorphanol (Tartrate) also known as Butorfanor tartarate, Butorfanor tartarate. . It is of Synthetic origin and belongs to Morphine-Opioid. It belongs to OPIATE agonist pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents pharmacological group.The Molecular Weight of Butorphanol (Tartrate) is 477.50.
Contraindications
Butorphanol (Tartrate) is contraindicated in conditions like Hypersensitivity to the drug.
Effects
The symptomatic adverse reactions produced by Butorphanol (Tartrate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Anxiety, Dyspnea, Palpitation, Insomnia, Tinnitus, Dry mouth, Confusion, Lethargy, Tremor, Asthenia, Nasal congestion, Stomachache, Xerostomia, Nasal irritation, Dry mouth, Confusion, dizziness.
Indications
Butorphanol (Tartrate) is primarily indicated in conditions like Headache, Labor pains, Migraine, Pre-anaesthetic medication, and can also be given in adjunctive therapy as an alternative drug of choice in Dental surgery.
Interactions
No data regarding the interactions of Butorphanol (Tartrate) was found.
Interfrence
Risks
Drug should not be given to Paediatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Aerosol, Inj Store Below 40°C. Protect from Sunlight and Heat.
Warnings
Butorphanol should be used with caution and in low doses in patients with respiratory depression, pulmonary disease, cardiac, renal or liver impairment, in GI disease including GI obstruction, ulcerative colitis or pre-existing constipation. Abrupt discontinuation or prolonged therapy can result in withdrawal symptoms.Although Cardio vascular Effects may be lessthan pentrazoline,butophanol should be generally avoided in M.I
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.